<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929483</url>
  </required_header>
  <id_info>
    <org_study_id>BIO89-100-122</org_study_id>
    <nct_id>NCT04929483</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)</brief_title>
  <acronym>ENLIVEN</acronym>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BIO89-100 in Subjects With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>89bio, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>89bio, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled study that will evaluate the safety,&#xD;
      efficacy, tolerability of BIO89-100 in patients with biopsy-confirmed fibrosis stages F2-F3&#xD;
      NASH.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants with histological resolution of NASH without worsening of fibrosis</measure>
    <time_frame>24 Weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants with ≥1 point decrease in fibrosis stage with no worsening of NASH</measure>
    <time_frame>24 Weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with at least a 2-point improvement in NAS and no worsening of fibrosis</measure>
    <time_frame>24 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with NASH resolution AND with ≥1 point decrease in fibrosis stage</measure>
    <time_frame>24 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change from baseline in triglycerides</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change from baseline in Low Density Lipoprotein (LDL) Cholesterol</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean absolute change and percentage change from baseline in Alanine Transaminase (ALT)</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean absolute change and percentage change from baseline in N-terminal type III collagen propeptide (Pro-C3)</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean absolute change and percentage change from baseline in Magnetic Resonance Imaging - Hepatic Fat Fraction (MRI-PDFF)</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change from baseline in HbA1c</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change from baseline in Adiponectin</measure>
    <time_frame>12 Weeks, 24 Weeks, 48 Weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Steady-state blood level of BIO89-100</measure>
    <time_frame>Blood samples for PK analysis collected at up to 8 study visits over the course of approximately 48 weeks</time_frame>
    <description>Plasma trough concentration (ng/mL) of BIO89-100 taken at pre-dose samples</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">216</enrollment>
  <condition>NASH - Nonalcoholic Steatohepatitis</condition>
  <arm_group>
    <arm_group_label>BIO89-100 - 15 mg QW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: BIO89-100 - 30 mg QW</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: BIO89-100 - 44 mg Q2W</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator: Placebo QW</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator: Placebo Q2W</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BIO89-100</intervention_name>
    <description>Subcutaneous injection</description>
    <arm_group_label>BIO89-100 - 15 mg QW</arm_group_label>
    <arm_group_label>Experimental: BIO89-100 - 30 mg QW</arm_group_label>
    <arm_group_label>Experimental: BIO89-100 - 44 mg Q2W</arm_group_label>
    <arm_group_label>Placebo Comparator: Placebo Q2W</arm_group_label>
    <arm_group_label>Placebo Comparator: Placebo QW</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Age 21 to 75&#xD;
&#xD;
          -  Biopsy-confirmed NASH with fibrosis stage F2 or F3 and NAS ≥4, with a score of at&#xD;
             least 1 in each of steatosis, ballooning degeneration, and lobular inflammation.&#xD;
&#xD;
             - Qualifying biopsy must be either within 6 months of screening visit or obtained&#xD;
             during screening period&#xD;
&#xD;
          -  Have obvious signs of NASH based on a number of blood tests and scans completed by a&#xD;
             Health Care Provider including the following:&#xD;
&#xD;
               -  Evidence of steatosis (MRI-PDFF ≥8%)&#xD;
&#xD;
               -  Increased metabolic risk; must have at least 2 of the following: Central obesity,&#xD;
                  Type 2 diabetes mellitus, increased fasting triglycerides, reduced fasting HDL-c&#xD;
&#xD;
               -  FibroScan® score ≥8.5 kPa&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Have poorly controlled high blood pressure&#xD;
&#xD;
          -  Have type 1 diabetes or poorly controlled type 2 diabetes.&#xD;
&#xD;
          -  History of cirrhosis or evidence of cirrhosis by clinical, imaging or liver biopsy&#xD;
             evaluation&#xD;
&#xD;
          -  Are planning to try to lose weight during the conduct of the study.&#xD;
&#xD;
          -  Have a BMI &lt;25 kg/m2&#xD;
&#xD;
        Other inclusion and exclusion criteria may apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charlton, MD</last_name>
    <role>Study Director</role>
    <affiliation>89bio, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Trial Lead</last_name>
    <phone>1-408-332-4389</phone>
    <email>jessenia.perez@89bio.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Guntersville</city>
        <state>Alabama</state>
        <zip>35976</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Madison</city>
        <state>Alabama</state>
        <zip>35768</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <zip>85381</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Huntington Park</city>
        <state>California</state>
        <zip>90255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92866</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Panorama City</city>
        <state>California</state>
        <zip>91402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Rialto</city>
        <state>California</state>
        <zip>92377</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33472</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Miami Lakes</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33147</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34471</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Pinellas Park</city>
        <state>Florida</state>
        <zip>33781</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46635</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Marrero</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Monroe</city>
        <state>Louisiana</state>
        <zip>71201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Greenbelt</city>
        <state>Maryland</state>
        <zip>20770</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Florham Park</city>
        <state>New Jersey</state>
        <zip>07932</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Concord</city>
        <state>North Carolina</state>
        <zip>28027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Springboro</city>
        <state>Ohio</state>
        <zip>45066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Greenwood</city>
        <state>South Carolina</state>
        <zip>29646</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Summerville</city>
        <state>South Carolina</state>
        <zip>29485</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37411</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Hermitage</city>
        <state>Tennessee</state>
        <zip>37076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78757-8051</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78757-8059</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Edinburg</city>
        <state>Texas</state>
        <zip>78539</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Garland</city>
        <state>Texas</state>
        <zip>75247</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77058</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77099</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-4801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-5069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Wichita Falls</city>
        <state>Texas</state>
        <zip>76301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Riverton</city>
        <state>Utah</state>
        <zip>84065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Sandy</city>
        <state>Utah</state>
        <zip>84092</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>89bio Clinical Study Site</name>
      <address>
        <city>San Juan</city>
        <zip>00927</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>89bio Clinical Study Site</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver Diseases</keyword>
  <keyword>Fatty Liver</keyword>
  <keyword>Digestive System Diseases</keyword>
  <keyword>Non-alcoholic Fatty Liver Disease</keyword>
  <keyword>Metabolic diseases</keyword>
  <keyword>NASH NAFLD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

